Article
Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Thrombosis research - 1 Jan 2014
Orikaza Cristina M, Morelli Vânia M, Matos Marinez F, Lourenço Dayse M
Abstract excerpt
INTRODUCTION: Cerebral venous thrombosis (CVT) is an uncommon disease with some differences compared to other-site thrombosis, including a higher frequency in young people, female sex and oral contraceptive users. Thrombin-activatable fibrinolysis inhibitor (TAFI) is a regulator of fibrinolysis, whose levels are genetically controlled and its increase is associated to thrombosis. Our objective was to investigate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
